This inventor holds 1 USPTO granted patent. Top assignee: Astellas Pharma Gmbh. Active years: 2013.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2013
Title: Innovations by Tadatsura Koshika: A Key Contributor to Inflammatory Disease Treatment
Introduction
Tadatsura Koshika is an accomplished inventor based in Tokyo, Japan, known for his contributions to the field of medicinal chemistry. With a focus on developing compounds that address significant health issues, Koshika has made noteworthy strides, particularly in the treatment of inflammatory diseases.
Latest Patents
Koshika holds a patent for an aza-bridged-ring compound, which exhibits an antagonistic action on muscarinic M receptors. This compound serves as a critical active ingredient for prophylactic and therapeutic agents targeting inflammatory diseases, including chronic obstructive pulmonary disease (COPD) and asthma. The innovative approach involves utilizing the unique properties of the aza-bridged-ring to successfully inhibit the binding of muscarinic receptors, paving the way for effective therapeutic strategies.
Career Highlights
Tadatsura Koshika is currently affiliated with Astellas Pharma GmbH, where he engages in cutting-edge research to develop new pharmacological solutions. His work is characterized by a commitment to improving patient outcomes through innovative medicinal formulations. Koshika has significantly impacted the field with his patent, reflecting his dedication to advancing healthcare solutions.
Collaborations
Throughout his career, Koshika has collaborated with esteemed colleagues, including Shinya Nagashima and Toru Kontani. These partnerships highlight the importance of teamwork in the pursuit of groundbreaking inventions and the sharing of knowledge within the pharmaceutical community.
Conclusion
In summary, Tadatsura Koshika has established himself as a significant figure in the realm of medicinal innovation. His patent for the aza-bridged-ring compound exemplifies the ongoing efforts to tackle challenging health issues such as COPD and asthma. Through his role at Astellas Pharma GmbH and collaborations with talented colleagues, Koshika continues to contribute to advancements in the treatment of inflammatory diseases, affirming his position as a respected innovator in the pharmaceutical industry.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile